KATHERINE PEIL: Open Payments
NPI 1467061481 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,540 in 134 payments from 22 companies in 2025. Trend: 2023 $1,822 · 2024 $2,201 · 2025 $2,540
Food & beverage: $2,540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $618 |
| Janssen Biotech, Inc. | 24 | $489 |
| Lilly USA, LLC | 12 | $241 |
| Phathom Pharmaceuticals, Inc. | 8 | $187 |
| Madrigal Pharmaceuticals | 9 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Ardelyx, Inc. | 4 | $104 |
| Braintree Laboratories, Inc. | 3 | $77 |
| Ipsen Biopharmaceuticals, Inc | 3 | $77 |
| Biocon Biologics Inc | 3 | $70 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, OMVOH, REZDIFFRA, ENTYVIO, IBSRELA, DUPIXENT.
Industry payments across SC — which companies pay providers there.
